Institutional shares held 27.8 Million
100 calls
0 puts
Total value of holdings $480M
$1K calls
$0 puts
Market Cap $540M
31,368,500 Shares Out.
Institutional ownership 88.52%
# of Institutions 87


Latest Institutional Activity in TRDA

Top Purchases

Q3 2024
Bay Bridge Capital Group, LLC Shares Held: 29K ($500K)
Q3 2024
Sg Americas Securities, LLC Shares Held: 9.75K ($168K)
Q3 2024
Us Bancorp \De\ Shares Held: 2.66K ($45.8K)
Q3 2024
Cwm, LLC Shares Held: 150 ($2.58K)
Q3 2024
Concourse Financial Group Securities, Inc. Shares Held: 0 ($0)

Top Sells

Q3 2024
Allspring Global Investments Holdings, LLC Shares Held: 20.5K ($354K)
Q3 2024
Nisa Investment Advisors, LLC Shares Held: 21 ($362)
Q2 2024
Redmile Group, LLC Shares Held: 561K ($9.67M)
Q2 2024
Advantage Alpha Capital Partners LP Shares Held: 20 ($345)
Q2 2024
Morgan Stanley Shares Held: 49.1K ($845K)

About TRDA

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.


Insider Transactions at TRDA

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
372K Shares
From 8 Insiders
Grant, award, or other acquisition 273K shares
Exercise of conversion of derivative security 53.4K shares
Open market or private purchase 45.4K shares
Sell / Disposition
116K Shares
From 8 Insiders
Payment of exercise price or tax liability 28.3K shares
Open market or private sale 87.6K shares

Track Institutional and Insider Activities on TRDA

Follow Entrada Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRDA shares.

Notify only if

Insider Trading

Get notified when an Entrada Therapeutics, Inc. insider buys or sells TRDA shares.

Notify only if

News

Receive news related to Entrada Therapeutics, Inc.

Track Activities on TRDA